InterCure Ltd.

INCR

$5.26

-2.95%

N/A-$0.16

Healthcare

Drug Manufacturers - Specialty & Generic

NASDAQ

Active Trading

InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Loading executive datasets...

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Amos Cohen	Chief Financial Officer	ILS 1,287,000		1979	Active
Alexander Rabinovich	Chief Executive Officer & Chairman	ILS 734,000		1971	Active
Einat Zehavi	Vice President of Sales	ILS 678,000	—	—	Active
Itai Kabiljo	General Counsel	—	—	—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of INCR

RELATIONS

Upstream

Organigram Global Inc.NASDAQ:OGI Charlotte's Web Holdings Inc.OTC:CWBHF Tilray Brands Inc.NASDAQ:TLRYCookies (SF Brands LLC)Praetorian Global Inc. (Binske)Cannasoul R&D Ltd.General cultivation input suppliers (lighting, HVAC, hydroponics, nutrients, growing media)

Downstream

S.L.E. Ltd. (subsidiary of Teva Pharmaceutical Industries)NYSE:TEVAMedical Cannabis Patients – IsraelMedical Cannabis Patients – Germany / EUCookies Brand Pharmacies (Germany, UK, Austria)Botanico Ltd. (ISHI – acquired entity)

Proxies

Organigram Global Inc.NASDAQ:OGITikun Olam-Cannbit Pharmaceuticals Ltd.TASE:TKUNSeach Medical Group Ltd.TASE:SEMGTeva Pharmaceutical Industries Ltd.NYSE:TEVA Tilray Brands Inc.NASDAQ:TLRY

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer